beta
AST
Asterias Biotherapeutics Inc. Common Series A
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Asterias Biotherapeutics Inc is a biotechnology company engaged in developing and commercializing therapies in the fields of cell therapy and regenerative medicine.
Market Cap: 125 Million
Primary Exchange: NYSE American
Website: http://www.asteriasbiotherapeutics.com
Shares Outstanding: 54.2 Million
Float: 52.9 Million
Dividend: 0.0 (0.0%)
Beta: 0.998727
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 973 trading days
From: 2015-04-24 To: 2019-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|